A faster method for collecting pure malaria parasites from infected mosquitos could accelerate the development of new, more potent malaria vaccines.
Researchers have designed a device that delivers two medications that help stop HIV transmission.
What The Study Did: In this survey study, COVID-19 was associated with large reductions in economic security among women at high risk of HIV infection in Kenya. However, shifts in sexual behavior may have temporarily decreased their risk of HIV infection.
The role of people infected with malaria without showing symptoms presents a hidden risk to efforts to control the disease after they were found to be responsible for most infections in mosquitoes, according to a study published in The Lancet Infectious Diseases.
Rising numbers of liver cancer in Aboriginal and Torres Strait Islander communities has led experts at Flinders University to call for more programs, including mobile liver clinics and ultrasound in rural and remote Australia. The Australian study just published in international Lancet journal EClinicalMedicine reveals the survival difference was largely accounted for by factors other than Indigenous status - including rurality, comorbidity burden and lack of curative therapy.
New research shows pregnant women exposed to higher levels of air pollution have babies who grow unusually fast in the first months after birth, putting on excess fat that may put them at risk of obesity and related diseases later in life.
In a new study, the researchers found that the common respiratory virus jump-starts the activity of interferon-stimulated genes, early-response molecules in the immune system which can halt replication of the SARS-CoV-2 virus within airway tissues infected with the cold.
State-of-the-art video microscopy has enabled Australian researchers to see the molecular details of how malaria parasites invade red blood cells - a key step in the disease.
New treatment combination for hepatitis C virus (HCV) is an additional affordable option for millions still waiting for access to lifesaving treatments in middle-income countries. Combination is safe and effective, including for hard-to-treat cases and people with HCV and HIV. New drug ravidasvir is the first HCV drug to be developed through South-South collaboration and with support from non-profit organizations.
A phase III clinical trial led by an investigator at the Medical University of South Carolina found that a novel four-month regimen was just as effective at treating tuberculosis as the standard six-month regimen. The findings are reported in the May 6, 2021 New England Journal of Medicine.